US Patent 8216567 Therapeutic ribonucleases
Patent 8216567 was granted and assigned to Quintessence Biosciences on July, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 13, 2011
Date of Patent
July 10, 2012
Patent Application Number
13231050
Patent Inventor Names
Laura Strong
0
Tony Klink
0
John Kink
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8216567 Therapeutic ribonucleases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.